{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:52:44Z","timestamp":1794660764900,"version":"4.9.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":1913,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with a high risk of sudden cardiac death. Three different prediction models for the indication of implanted cardioverter defibrillator (ICD) are now available: the 5 year ARVC risk score, the International Task Force Consensus (ITFC) criteria, and the Heart Rhythm Society (HRS) criteria. We compared these three prediction models in a validation cohort of patients with definite ARVC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In a cohort of 140 patients with definite ARVC, the 5 year ARVC risk score and the ITFC and HRS criteria were compared for the prediction of a major combined endpoint of sudden cardiac death, appropriate ICD intervention, resuscitated cardiac arrest, and sustained ventricular tachycardia. During the follow-up, 65 major events occurred. The 5 year ARVC risk score with a threshold &amp;gt;10%, derived from the maximally selected rank statistic, predicted 62 (95%) events [odds ratio (OR) 9.1, 95% confidence interval (CI) 2.6\u201332, P = 0.0006], the ITFC criteria 53 (81%, OR 4.8, 95% CI 2.2\u201310.3, P = 0.0001), and the HRS criteria 29 (45%, OR 4.2, 95% CI 1.9\u20139.3, P = 0.0003). At the analysis of decision curve for ICD implantation, a 5 year ARVC risk score &amp;gt;10% showed a greater net benefit than the ITFC and HRS criteria over a wide range of threshold probability of events. Finally, at multivariate analysis, the 5 year ARVC risk score &amp;gt;10% was the only independent predictor of major events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The 5 year score with a threshold of &amp;gt;10% was more effective for predicting events than the ITFC and HRS criteria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13019","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T10:10:10Z","timestamp":1600855810000},"page":"4080-4088","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Comparison of Different Prediction Models for the Indication of Implanted Cardioverter Defibrillator in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy"],"prefix":"10.1093","volume":"7","author":[{"given":"Giovanni Donato","family":"Aquaro","sequence":"first","affiliation":[{"name":"Fondazione Toscana G. Monasterio , Via Giuseppe Moruzzi, 1, Pisa, 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Luca","sequence":"additional","affiliation":[{"name":"Cardio-thoraco-vascular Department, University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cappelletto","sequence":"additional","affiliation":[{"name":"Cardio-thoraco-vascular Department, University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Raimondi","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology, H\u00f4pital Necker-Enfants Malades , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bianco","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, \u2018G. d'Annunzio\u2019 University , Chieti ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Botto","sequence":"additional","affiliation":[{"name":"Fondazione Toscana G. Monasterio , Via Giuseppe Moruzzi, 1, Pisa, 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Barison","sequence":"additional","affiliation":[{"name":"Fondazione Toscana G. Monasterio , Via Giuseppe Moruzzi, 1, Pisa, 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Romani","sequence":"additional","affiliation":[{"name":"Cardio-thoraco-vascular Department, University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Lesizza","sequence":"additional","affiliation":[{"name":"Cardio-thoraco-vascular Department, University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fabris","sequence":"additional","affiliation":[{"name":"Cardio-thoraco-vascular Department, University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Todiere","sequence":"additional","affiliation":[{"name":"Fondazione Toscana G. Monasterio , Via Giuseppe Moruzzi, 1, Pisa, 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crysanthos","family":"Grigoratos","sequence":"additional","affiliation":[{"name":"Fondazione Toscana G. Monasterio , Via Giuseppe Moruzzi, 1, Pisa, 56124 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pingitore","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology, National Council of Research , Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Stolfo","sequence":"additional","affiliation":[{"name":"Cardio-thoraco-vascular Department, University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Dal Ferro","sequence":"additional","affiliation":[{"name":"Cardio-thoraco-vascular Department, University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Merlo","sequence":"additional","affiliation":[{"name":"Cardio-thoraco-vascular Department, University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Di Bella","sequence":"additional","affiliation":[{"name":"University of Messina , Messina ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[{"name":"Cardio-thoraco-vascular Department, University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"2026012115024020900_ehf213019-bib-0001","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.jacc.2008.09.019","article-title":"Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity","volume":"52","author":"Sen-Chowdhry","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026012115024020900_ehf213019-bib-0002","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.hlc.2018.10.013","article-title":"Arrhythmogenic cardiomyopathy in 2018\u20132019: ARVC\/ALVC or both?","volume":"28","author":"Bennett","year":"2019","journal-title":"Heart Lung Circ"},{"key":"2026012115024020900_ehf213019-bib-0003","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/CIRCULATIONAHA.117.030792","article-title":"Risk stratification in arrhythmogenic right ventricular cardiomyopathy","volume":"136","author":"Calkins","year":"2017","journal-title":"Circulation"},{"key":"2026012115024020900_ehf213019-bib-0004","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an international task force consensus statement","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation"},{"key":"2026012115024020900_ehf213019-bib-0005","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"key":"2026012115024020900_ehf213019-bib-0006","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"issue":"22","key":"2026012115024020900_ehf213019-bib-0007","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.jacc.2020.04.023","article-title":"Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"75","author":"Aquaro","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"key":"2026012115024020900_ehf213019-bib-0008","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the Task Force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"key":"2026012115024020900_ehf213019-bib-0009","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2026012115024020900_ehf213019-bib-0010","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.amjcard.2016.08.056","article-title":"Usefulness of combined functional assessment by cardiac magnetic resonance and tissue characterization versus task force criteria for diagnosis of arrhythmogenic right ventricular cardiomyopathy","volume":"118","author":"Aquaro","year":"2016","journal-title":"Am J Cardiol"},{"key":"2026012115024020900_ehf213019-bib-0011","doi-asserted-by":"crossref","first-page":"i6","DOI":"10.1136\/bmj.i6","article-title":"Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests","volume":"352","author":"Vickers","year":"2016","journal-title":"BMJ"},{"key":"2026012115024020900_ehf213019-bib-0012","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","article-title":"Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"108","author":"Corrado","year":"2003","journal-title":"Circulation"},{"key":"2026012115024020900_ehf213019-bib-0013","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006242","article-title":"Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: predictors of appropriate therapy, outcomes, and complications","volume":"6","author":"Orgeron","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026012115024020900_ehf213019-bib-0014","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"key":"2026012115024020900_ehf213019-bib-0015","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.amjcard.2018.08.007","article-title":"Prognostic role of cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy","volume":"122","author":"Aquaro","year":"2018","journal-title":"Am J Cardiol"},{"key":"2026012115024020900_ehf213019-bib-0016","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/jce.12222","article-title":"Mutation-positive arrhythmogenic right ventricular dysplasia\/cardiomyopathy: the triangle of dysplasia displaced","volume":"24","author":"Te Riele","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026012115024020900_ehf213019-bib-0017","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/eurheartj\/ehl380","article-title":"Desmoglein-2 mutations in arrhythmogenic right ventricular cardiomyopathy: a genotype-phenotype characterization of familial disease","volume":"28","author":"Syrris","year":"2007","journal-title":"Eur Heart J"},{"key":"2026012115024020900_ehf213019-bib-0018","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/eurheartj\/ehi341","article-title":"Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations","volume":"26","author":"Bauce","year":"2005","journal-title":"Eur Heart J"},{"key":"2026012115024020900_ehf213019-bib-0019","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12471-012-0274-x","article-title":"Geographical distribution of plakophilin-2 mutation prevalence in patients with arrhythmogenic cardiomyopathy","volume":"20","author":"Jacob","year":"2012","journal-title":"Neth Hear J"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13019","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/6\/4080\/65902593\/eschf_7_6_4080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/6\/4080\/65902593\/eschf_7_6_4080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:02:57Z","timestamp":1769025777000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/6\/4080\/8372466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,9,23]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13019","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"2020-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}